NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q3 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $115 | -83.9% | 200 | -80.3% | 0.00% | – |
| Q1 2023 | $713 | -68.9% | 1,015 | 0.0% | 0.00% | – |
| Q4 2022 | $2,294 | -42.6% | 1,015 | -14.7% | 0.00% | – |
| Q3 2022 | $4,000 | -69.2% | 1,190 | -63.8% | 0.00% | – |
| Q2 2022 | $13,000 | -23.5% | 3,291 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -52.8% | 3,291 | +24.6% | 0.00% | – |
| Q4 2021 | $36,000 | -23.4% | 2,641 | 0.0% | 0.00% | – |
| Q3 2021 | $47,000 | +176.5% | 2,641 | +160.2% | 0.00% | – |
| Q2 2021 | $17,000 | -15.0% | 1,015 | 0.0% | 0.00% | – |
| Q1 2021 | $20,000 | -41.2% | 1,015 | -49.6% | 0.00% | – |
| Q4 2020 | $34,000 | +3.0% | 2,015 | 0.0% | 0.00% | – |
| Q3 2020 | $33,000 | -29.8% | 2,015 | 0.0% | 0.00% | – |
| Q2 2020 | $47,000 | +161.1% | 2,015 | +98.5% | 0.00% | – |
| Q1 2020 | $18,000 | -18.2% | 1,015 | 0.0% | 0.00% | – |
| Q4 2019 | $22,000 | +22.2% | 1,015 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | +260.0% | 1,015 | +407.5% | 0.00% | – |
| Q3 2017 | $5,000 | +66.7% | 200 | +15.6% | 0.00% | – |
| Q2 2017 | $3,000 | -70.0% | 173 | -72.1% | 0.00% | – |
| Q4 2014 | $10,000 | – | 620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |